Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Journal of the American Academy of Dermatology|June 5, 2019
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled studyMegan H Noe, Marilyn T Wan, Daniel B Shin, et al.
International Journal of Dermatology|January 13, 2010
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studiesPeter Foley, Michael Freeman, Alan Menter, et al.
Lancet (London, England)|June 15, 2015
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsChristopher E M Griffiths, Kristian Reich, Mark Lebwohl, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Plos Genetics|March 29, 2008
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease lociYing Liu, Cynthia Helms, Wilson Liao, et al.
The Journal of Allergy and Clinical Immunology|September 9, 2018
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitisEmma Guttman-Yassky, Robert Bissonnette, Benjamin Ungar, et al.
American Journal of Human Genetics|April 24, 2012
PSORS2 is due to mutations in CARD14Catherine T Jordan, Li Cao, Elisha D O Roberson, et al.
The Journal of Investigative Dermatology|February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
American Journal of Human Genetics|April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasisCatherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Circulation. Cardiovascular Imaging|May 20, 2018
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled TrialNehal N Mehta, Daniel B Shin, Aditya A Joshi, et al.
Pageof 26